US Patent Issued to BUDDHIST TZU CHI MEDICAL FOUNDATION on Jan. 28 for "Mesenchymal stem cell derived exosomes and method for preventing or treating a joint disorder by administering a composition comprising the same" (Taiwanese Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,119, issued on Jan. 28, was assigned to BUDDHIST TZU CHI MEDICAL FOUNDATION (Hualien, Taiwan).

"Mesenchymal stem cell derived exosomes and method for preventing or treating a joint disorder by administering a composition comprising the same" was invented by Dah-Ching Ding (Hualien, Taiwan), Kun-Chi Wu (Hualien, Taiwan) and Yu-Hsun Chang (Hualien, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharmaceutical composition including an effective amount of mesenchymal stem cell derived exosomes. Also provided is a use of the pharmaceutical composition for preserving cartilage tissue, promoting cartilage regeneration and repairing dam...